Cancer Risk Seen with Johnson & Johnson Foot Gel, FDA Says

March 28, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON (Reuters) - A Johnson & Johnson foot gel used by diabetics may increase the risk of cancer and death, U.S. health officials said on Thursday in announcing an investigation into the issue.

Twitter
LinkedIn
Facebook
Email
Print

Johnson & Johnson Family of Companies Food and Drug Administration (FDA)